Patterns of Fos expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats

International Journal of Neuroscience

Volumn 118, Issue 8, 2008, Pages 1053-1079

  Reyes, Stephanie ^a   Mitrofanis, John ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b The Australian National University   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cell activity; Mechanical stimulation; Pain; Parkinson disease

Indexed keywords

BIOLOGICAL MARKER; OXIDOPAMINE; PROTEIN FOS; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FOREBRAIN; IMMUNOCYTOCHEMISTRY; MALE; MECHANICAL STIMULATION; NIGRONEOSTRIATAL SYSTEM; NOCICEPTION; NONHUMAN; PARKINSONISM; PERIAQUEDUCTAL GRAY MATTER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SPINAL CORD;

ANIMALS; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; LUMBAR VERTEBRAE; MALE; NEURAL PATHWAYS; NEURONS; NOCICEPTORS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PERIAQUEDUCTAL GRAY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SENSATION DISORDERS; SPINAL CORD; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TYROSINE 3-MONOOXYGENASE;

EID: 46049106342     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450701239210     Document Type: Article

References (85)

1. Abbadie, C., & Besson, J. (1993). c-fos expression in rat lumbar spinal cord following peripheral stimulation in adjuvant-induced arthritic and normal rats. Brain Research, 607, 195-204.
2. Albe-Fessard, D., Berkley, K. J., Kruger, L., Ralston, H. J., & Willis, W. D. (1985). Diencephalic mechanisms of pain sensation. Brain Research, 356, 217-296.
3. Albin, R., Young, A., & Penney, J. (1989). The functional anatomy of basal ganglia disorders. Trends in Neuroscience, 12, 366-375.
4. Barasi, S. (1979). Responses of substantia nigra neurones to noxious stimulation. Brain Research, 171, 121-130.
5. Barbaresi, P., Minelli, A., Gazzanelli, G., & Malatesta, M. (1994). Commissural connections of the cat periaqueductal gray matter studied with anterograde and retrograde tract-tracing techniques. Neuroscience, 60, 781-799.
6. Barnes, C. D., Fung, S. J., & Adams, W. L. (1979). Inhibitory effects of substantia nigra on impulse transmission from nociceptors. Pain, 6, 207-215.
7. Behebehani, M. M., Jian, M. R., Chandler, S. D., & Ennis, M. (1990). The effect of GABA and its antagonists on midbrain periaqueductal gray neurons in the rat. Pain, 40, 195-204.
8. Beitz, J. (1982). The organisation of afferent projections to the midbrain periaqueductal grey of rat. Neuroscience, 7, 133-159.
9. Benabid, A. L., Benazzouz, A., & Pollack, P. (2002). Mechanisms of deep brain stimulation. Movement Disorders, 17, S73-S74.
10. Benabid, A. L., Henriksen, S. J., McGinty, J. F., & Bloom, F. E. (1983). Thalamic nucleus ventro-postero-lateralis inhibits nucleus parafascicularis response to noxious stimuli through a non-opioid pathway. Brain Research, 280, 217-231.
11. Bergman, H., & Deuschl, G. (2002). Pathophysiology of Parkinson disease: From clinical neurology to basic neuroscience and back. Movement Disorders, 17, S28-40.
12. Bergman, H., Wichmann, T., Karmon, B., & DeLong, M. R. (1994). The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. Journal of Neurophysiology, 72, 507-520.
13. Besson, J. B., & Chaouch, A. (1989). Peripheral and spinal mechanisms of nociception. Physiological Reviews, 67, 67-181.
14. Bester, H., Matsumoto, N., & Besson, J. (1997). Further evidence for the involvement of the spinoparabrachial pathway in nociceptive processes: A c-fos study in the rat. Journal of Comparative Neurology, 383, 439-458.
15. Bezard, E., Boraud, T., Bioulac, B., & Gross, C. E. (1999). Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. European Journal of Neuroscience, 11, 2167-2170.
16. Blandini, F., Armentero, M. T., Fancellu, R., Blaugrund, E., & Nappi, G. (2004). Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease. Experimental Neurology, 187, 455-459.
17. Blandini, F., Nappi, G., Tassorelli, C., & Martignoni, E. (2000). Functional changes of the basal ganglia circuitry in Parkinson's disease. Progress in Neurobiology, 62, 63-88.
18. Breit, S., Bouali-Benazzouz, R., Benabid, A. L., & Benazzouz, A. (2001). Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. European Journal of Neuroscience, 14, 1833-1842.
19. Breit, S., Lessmann, L., Benazzouz, A., & Schulz, J. B. (2006). Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat. European Journal of Neuroscience, 22, 2283-2294.
20. Bullitt, E. (1989). Induction of c-fos- like protein within the lumbar spinal cord and thalamus of the rat following peripheral stimulation. Brain Research, 493, 391-397.
21. Bullitt, E., Lee, C., Light, A., & Willcockson, H. (1992). The effect of stimulus duration on noxious-stimulus induced c-Fos expression in the rodent spinal cord. Brain Research, 580, 172-179.
22. Carlson, J. D., Pearlstein, R. D., Buchholz, J., Iacono, R. P., & Maeda, G. (1999). Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's model rats. Brain Research, 828, 12-19.
23. Carlsson, A., Falk, B., Fuxe, K., & Hillard, N. A. (1964). Cellular localisation of monoamines in the spinal cord. Acta Physiology Scandinavia, 60, 112-119.
24. Carpenter, M. B., & McMasters, R. E. (1964). Lesions of the substantia nigra in the Rhesus monkey. Efferent fibre degeneration and behavioural observations. American Journal of Anatomy, 114, 293-319.
25. Cavorzin, P., Carrault, G., Chagneau, F., & Rochcongar, P. (2003). A computer model of rigidity and related motor dysfunctions in Parkinson disease. Movement Disorders, 18, 1257-1265.
26. Chudler, E., & Dong, W. (1995). The role of the basal ganglia in nociception and pain. Pain, 60, 3-38.
27. Clement, C., Keay, K., & Bandler, R. (1998). Medullary catecholaminergic projections to the ventrolateral periaqueductal gray region activated by halothane anaesthesia. Neuroscience, 86, 1273-1284.
28. Clement, C., Keay, K., Owler, B., & Bandler, R. (1996). Common patterns of increased and decreased fos expression in midbrain and pons evoked by noxious deep somatic and noxious visceral manipulations in the rat. Journal Comparative Neurology, 366, 495-515.
29. Clement, C., Keay, K., Podzebenko, K., Gordon, B., & Bandler, R. (2000). Spinal sources of noxious visceral and noxious deep somatic afferent drive onto the ventrolateral periaqueductal grey of the rat. Journal Comparative Neurology, 370, 323-344.
30. Conley, S., & Kirchner, J. (1999). Parkinson disease - the shaking palsy. Postgraduate Medicine, 106, 39-52.
31. Depaulis, A., & Vergnes, M. (1986). Elicitation of intraspecific defensive behaviours in the rat by microinjection of picrotoxin, a g-aminobutyric acid antagonist, into the midbrain periaqueductal grey matter. Brain Research, 367, 87-95.
32. Fallon, J. H., & Moore, R. Y. (1978). Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. Journal Comparative Neurology, 180, 545-580.
33. Fitzpatrick, E., Ashkan, K., Wallace, B. A., Benabid, A. L., & Mitrofanis, J. (2005). Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats. Anatomy & Embryology, 210, 101-123.
34. Fleetwood-Walker, S. M., Hope, P. J., & Mitchell, R. (1988). Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. Journal of Physiology, 399, 335-348.
35. Fuhr, P., Zeffiro, T., & Hallett, M. (1992). Cutaneous reflexes in Parkinson's disease. Muscle & Nerve, 15, 733-739.
36. Goetz, C., Tanner, C., Levy, M., Wilson, R., & Garron, D. (1986). Pain in Parkinson's disease. Movement Disorders, 1, 45-49.
37. Hagihira, S., Taenaka, N., & Yoshiya, I. (1997). Inhalation anaesthetics suppress the expression of c-Fos protein evoked by noxious somatic stimulation in the deeper layer of the spinal cord in the rat. Brain Research, 751, 124-130.
38. Haslinger, B., Erhard, P., Kampfe, N., Boecker, H., Rummeny, E., Schwaiger, M., Conrad, B., & Ceballos-Baumann, A. O. (2001). Event-related functional magnetic resonance imaging in Parkinson disease before and after levodopa. Brain, 24, 558-570.
39. Heise, C. E., & Mitrofanis, J. (2006). Fos immunoreactivity in some locomotor nuclei of 6OHDA-lesioned rats. Anatomy & Embryology, 211, 659-671.
40. Heise, C. E., Teo, Z. C., Wallace, B. A., Ashkan, K., Benabid, A. L., & Mitrofanis, J. (2005). Cell survival patterns in the pedunculopontine tegmental nucleus of MPTP-treated monkeys and 6OHDA-lesioned rats: Evidence for differences to idiopathic Parkinson disease patients? Anatomy & Embryology, 210, 287-302.
41. Hunt, S. P., Pini, A., & Evan, G. (1987). Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature, 328, 632-634.
42. Jansen, A. S., Farkas, E., MacSams, J., & Loewy, A. D. (1998). Local connections between the columns of the periaqueductal gray matter: A case for intrinsic neuromodulation. Brain Research, 784, 329-336.
43. Jinks, S. L., Antognini, J. F., Martin, J. T., Jung, S., Carstens, E., & Atherley, R. (2002). Isoflurane, but not halothane, depresses c-fos expression in rat spinal cord at concentrations that suppress reflex movement after supramaximal noxious stimulation. Anaesthetics & Analgesia, 95, 1622-1628.
44. Jurna, I., Heinz, G., Blinn, G., & Nell, T. (1978). The effect of substantia nigra stimulation and morphine on alpha-motoneurones and the tail-flick response. European Journal of Pharmacology, 51, 239-250.
45. Keay, K., & Bandler, R. (1993). Deep and superficial noxious stimulation increases Fos-like immunoreactivity in different regions of the midbrain periaqueductal grey of the rat. Neuroscience Letters, 154, 23-26.
46. Keay, K., Clement, C., Depaulis, A., & Bandler, R. (2001). Different representations of inescapable noxious stimuli in the periaqueductal gray and upper cervical spinal cord of freely moving rats. Neuroscience Letters, 313, 17-20.
47. Keay, K., Clement, C., Matar, W., Heslop, D., Henderson, L., & Bandler, R. (2002). Noxious activation of spinal or vagal afferents evoke distinct patterns of fos-like immunoreactivity in the ventrolateral periaqueductal gray of unanaesthetised rats. Brain Research, 948, 122-130.
48. Keay, K., Feil, K., Gordon, B., Herbert, H., & Bandler, R. (1997). Spinal afferents to functionally distinct periaqueductal grey columns in the rat: An anterograde and retrograde tracing study. Journal of Comparative Neurology, 385, 207-229.
49. Kizer, J. S., Palkovits, M., Kopin, I. J., Saavedra, J. M., & Brownstein, M. J. (1976). Lack of effect of various endocrine manipulations on tryptophan hydroxylase activity of individual nuclei of the hypothalamus, limbic system, and midbrain of the rat. Endocrinology, 98, 743-747.
50. Klockgether, T. (2004). Parkinson's disease: Clinical aspects. Cell & Tissue Research, 318, 115-120.
51. Kuypers, H. G., & Maisky, V. A. (1975). Retrograde axonal transport of horseradish peroxidase from spinal cord to brain stem cell groups in the cat. Neuroscience Letters, 1, 9-14.
52. Lin, M. T., Wu, J. J., Chandra, A., & Tsai, B. L. (1981). Activation of striatal dopamine receptors induces pain inhibition in rats. Journal of Neural Transmission, 51, 213-222.
53. Liu, R., & Hamilton, B. (1986). Neurons of the periaqueductal gray matter as revealed by Golgi study. Journal of Comparative Neurology, 189, 403-418.
54. Menetrey, D., Chaouch, A., Binder, D., & Besson, J. M. (1982). The origin of the spinomesencephalic tract in the rat: An anatomical study using the retrograde transport of horseradish peroxidase. Journal of Comparative Neurology, 206, 193-207.
55. Mitchell, I. J., Clarke, C. E., Boyce, S., Robertson, R. G., Peggs, D., Sambrook, M. A., & Crossman, A. R. (1989). Neural mechanisms underlying parkinsonian symptoms based on regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience, 32, 213-226.
56. Morgan, M. J., & Franklin, K. B. (1990). 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Research, 519, 144-149.
57. Mouton, L., VanderHorst, V., & Holstege, G. (1997). Large segmental differences in the spinal projections to the periaqueductal gray in the cat. Neuroscience Letters, 238, 1-4.
58. Munglani, R., & Hunt, S. (1995). Proto-oncogenes: Basic concepts and stimulation induced changes in the spinal cord. Progress in Neurobiology, 104, 283-297.
59. Orieux, G., Francois, C., Feger, J., & Hirsch, E. C. (2002). Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. Journal of Neuroscience, 22, 8762-8770.
60. Orieux, G., Francois, C., Feger, J., Yelnik, J., Vila, M., Ruberg, M., Agid, Y., & Hirsch, E. C. (2000). Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson disease. Neuroscience, 97, 79-88.
61. Parent, A. (1996). Carpenters human neuroanatomy. 9th edn. New York: Williams & Wilkins.
62. Paul, G., Meissner, W., Rein, S., Harnack, D., Winter, C., Hosmann, K., Morgenstern, R., & Kupsch, A. (2004). Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson disease. Experimental Neurology, 185, 272-280.
63. Paxinos, G., & Watson, C. (2005). The rat brain in stereotaxic coordinates. London: Elsevier Academic Press.
64. Pay, S., & Barasi, S. (1982). A study of the connections of nociceptive substantia nigra neurones. Pain, 12, 75-89.
65. Peschanski, M., & Besson, J. M. (1984). Diencephalic connections of the raphe nuclei of the rat brainstem: An anatomical study with reference to the somatosensory system. Journal of Comparative Neurology, 224, 509-534.
66. Petko, M., & Antal, M. (2000). Propriospinal afferent and efferent connections of the lateral and medial areas of the dorsal horn (laminae I-IV). in the rat lumbar spinal cord. Journal of Comparative Neurology, 422, 312-325.
67. Petko, M., Veress, G., Vereb, G., Storm-Mathisen, J., & Antal, M. (2004). Commissural propriospinal connections between the lateral aspects of laminae III-IV in the lumbar spinal cord of rats. Journal of Comparative Neurology, 480, 364-377.
68. Piallat, B., Benazzouz, A., & Benabid, A. L. (1996). Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: Behavioural and immunohistochemical studies. European Journal of Neuroscience, 8, 1408-1414.
69. Presley, R. W., Menetrey, D., Levine, J. D., & Basbaum, A. I. (1990). Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. Journal of Neuroscience, 10, 323-335.
70. Quinn, N., Koller, W., Lang, A., & Marsden, C. (1986). Painful Parkinson's disease. Lancet, 1, 1366-1369.
71. Reyes-Vazquez, C., Qiao, J. T., & Dafny, N. (1989). Nociceptive responses in nucleus parafascicularis thalami are modulated by dorsal raphe stimulation and microiontophoretic application of morphine and serotonin. Brain Research Bulletin, 23, 405-411.
72. Saade, N. E., Atweh, S. F., Bahuth, N. B., & Jabbur, S. J. (1997). Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Research, 751, 1-12.
73. Sabatini, U., Boulanouar, K., Fabre, N., Martin, F., Carel, C., Colonnese, C., Bozzao, L., Berry, I., Montastruc, J. L., Chollet, F., & Rascol, O. (2000). Cortical motor reorganisation in akinetic patients with Parkinson disease: A functional MRI study. Brain, 123, 394-403.
74. Salin, P., Manrique, C., Forni, C., & Kerkerian-Le Goff, L. (2002). High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. Journal of Neuroscience, 22, 5137-5148.
75. Sandyk, R. (1986). Sensory symptoms in Parkinson's disease. Pain, 25, 139-140.
76. Sandyk, R., & Bamford, C. (1988). Pain and sensory symptoms in Parkinson's disease. International Journal of Neuroscience, 39, 15-25.
77. Sandyk, R., & Iacono, R. (1987). Spinal dopamine mechanisms and primary sensory symptoms in Parkinson's disease. International Journal of Neuroscience, 32, 927-931.
78. Schober, A. (2004). Classic toxin-induced animal models of Parkinson's disease: 6OHDA and MPTP. Cell & Tissue Research, 318, 215-224.
79. Stein, J. F., & Aziz, T. Z. (1999). Does imbalance between basal ganglia and cerebellar outputs cause movement disorders? Current Opinion in Neurology, 12, 667-669.
80. Steiner, H., & Kitai, S. T. (2001). Unilateral striatal dopamine depletion: Time-dependent effects on cortical function and behavioural correlates. European Journal of Neuroscience, 14, 1390-1404.
81. Stezhka, V. V., & Lovick, T. A. (1997). Projections from dorsal raphe nucleus to the periaqueductal grey matter: Studies in slices of rat midbrain maintained in vitro. Neuroscience Letters, 230, 57-60.
82. Tsai, C. T. (1989). Involvement of serotonin in mediation of inhibition of substantia nigra neurons by noxious stimuli. Brain Research Bulletin, 23, 121-127.
83. Tsai, C. T., Nakamura, S., & Iwama, K. (1980). Inhibition of neuronal activity of the substantia nigra by noxious stimuli and its modification by the caudate nucleus. Brain Research, 195, 299-311.
84. Williams, S., Evan, G. I., & Hunt, S. P. (1990). Changing patterns of c-fos induction in spinal neurons following thermal cutaneous stimulation in the rat. Neuroscience, 36, 73-81.
85. Yezierski, R. P., & Mendez, C. M. (1991). Spinal distribution and collateral projections of rat spinomesencephalic tract cells. Neuroscience, 44, 113-130.